Todd Pope - 09 Jun 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Todd Pope by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 16:21:51 UTC
Previous filing
15 Oct 2021
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +8,500 $0.000000 8,500 09 Jun 2022 Common Stock 8,500 $4.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.